Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. - Wikidata - awgldk - TriplyDB

Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes.

Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes.

http://www.wikidata.org/entity/Q37297099

about

Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice.Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Pharmacotherapy for end-stage coronary artery disease.Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia Effects of diabetes mellitus on VEGF-induced proliferation response in bone marrow derived endothelial progenitor cells Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia Temporal and spatial changes in collateral formation and function during chronic myocardial ischemia Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia Modeling chick to assess diabetes pathogenesis and treatment.Role of autophagy in angiogenesis in aortic endothelial cells.Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia.Resveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome.Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction.Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectoris Diabetes impairs stem cell and proangiogenic cell mobilization in humans.Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart.Insulin treatment enhances the myocardial angiogenic response in diabetes Human studies of angiogenic gene therapy.Exercise increases serum endostatin levels in female and male patients with diabetes and controls.Heart failure with preserved ejection fraction in the elderly: scope of the problem.Pathophysiology of myocardial injury and remodeling: implications for molecular imaging.Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease.Angiogenic gene therapy for refractory angina.Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats.The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles Effects of prolonged ingestion of epigallocatechin gallate on diabetes type 1-induced vascular modifications in the erectile tissue of rats.Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic mice.

P2860

Q26991985-FCE160E9-C0CE-4D44-B8EA-000E12F65680 Q33331474-92C46130-B43E-4E31-9EC6-5FDD615A247E Q33556657-F6BB27F2-A6E3-4BD5-A437-0F2374E5FE4E Q33610142-0B3E00C1-57E0-4DB7-8A4D-8F2717BFA0C1 Q33765479-B6319D03-E230-418B-80D8-3866A996D86C Q34147482-3CAD9B6B-FC5F-4FB9-91FE-15D295B2FED5 Q34217568-F0BA7FB1-204C-454D-9B83-5792AD9BBEEA Q34288422-CCD2EBC2-178C-4925-B428-59F96F97739C Q34549687-1ABF7FDC-719B-4D50-BB5E-02CBD010D996 Q34604496-6CC6F552-2597-4114-B017-0C44705D257E Q35072520-9D1F1B97-D5B1-4651-81CF-38B0303AC3A8 Q35757774-8A1419C5-5386-431E-BE35-4FC8B27F72E6 Q35758475-877ADA1E-EC70-4A05-AB3B-9FBA01908001 Q35895542-A7F68C12-E0A1-45CE-902A-1FE6CBD09485 Q36143074-5F16ED08-3C5B-427A-AB74-8B808AFA1437 Q36339075-9F87A22B-F329-47F3-ADA8-2ECC6D4CE5AF Q36403217-0AE98FEB-0FE3-4649-9541-BBE6DB9FBFD6 Q36579691-499A73F9-CD91-43CF-82D1-0CC5DB885B57 Q36687489-DD3570DB-9607-4876-BBC7-A7CDF16751C1 Q36720330-326CD2FB-2216-4C05-BD49-52C1878DE404 Q36800392-C8873028-1FD2-4D7F-AF5F-3A5CD90FBE88 Q36820684-3F8898D1-1A44-43D9-ABB3-35F3FBF5B9D4 Q36998592-BA565A87-07B1-4302-9239-75AFC1807817 Q37180237-C431EDE2-D985-4199-B6FA-E4C3BDCB2601 Q37406656-9BC09E37-1D35-423D-8250-61EFAE5AC485 Q37554657-86205505-0FBC-4B9B-8CFC-8F56D97BDD99 Q37633991-327F4044-ABC4-482D-8A9B-55180432B27F Q37731738-CB5571B7-28DC-45D4-A0E9-0C3E40899FD8 Q38081027-C5BAD00E-66F9-4414-855B-5243F41D721C Q38121606-83C16BF4-9855-46DD-92AB-1C0656ADBC19 Q38637597-43C635DF-9A36-4B26-B255-5AA322D7516B Q38915485-39A06D69-A05E-408F-9792-A9A4007A7614 Q40985253-44FE9B0A-04C7-4937-81ED-01CD2D85D2EB Q42148995-3B74523D-68BC-4E4C-9328-985B00D05C42 Q53103069-DCCBBEBF-2068-4A5A-8EE4-B3DB370CB79A Q54433790-23BEA9FF-1164-440C-ABAC-6D11D1BE486A

P2860

Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes.

http://www.wikidata.org/entity/Q37297099

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional, cellular, and mole ...... ocardial ischemia in diabetes.

@en

Functional, cellular, and mole ...... ocardial ischemia in diabetes.

@nl

type

label

Functional, cellular, and mole ...... ocardial ischemia in diabetes.

@en

Functional, cellular, and mole ...... ocardial ischemia in diabetes.

@nl

prefLabel

Functional, cellular, and mole ...... ocardial ischemia in diabetes.

@en

Functional, cellular, and mole ...... ocardial ischemia in diabetes.

@nl

P1433

Q37297099-454A7F95-670D-4969-A0ED-06F883944D5D

P1476

Q37297099-C2262837-FE38-4FE6-B2D2-481107D2BFB4

P2093

Q37297099-4851134B-2325-4182-8F28-798A79EE1D99

Q37297099-48D66C8D-F99C-475D-86DE-158CD7434C0F

Q37297099-79E09767-4BB6-4141-853A-C79B8EAFC3BD

Q37297099-90B203CB-6D03-4768-A1F2-BF70ECA473B4

Q37297099-C2FFBC26-A1F9-4FB5-9B54-B82E89ECC4C5

Q37297099-D8F7006E-3CBA-4A0C-9760-4DFB2E6B06EF

Q37297099-DAC95572-8323-405F-A301-F9D5B873AEE1

Q37297099-EE921B20-1408-463D-A7AD-E19997C5EF4C

P2860

Q37297099-01BF25F7-7CF6-4A42-86F1-6889A81B579F

Q37297099-03DEBEEA-9D76-49A2-B7A6-81341FAFBF4F

Q37297099-21A6BC11-13FC-40B5-BC21-E686371A81C7

Q37297099-2D057C84-E146-4D70-B387-7F839C1CEB06

Q37297099-3438CF50-CC78-40FF-A00C-2BDB416EE9F2

Q37297099-3EBBCBCF-C739-401F-BED3-7D85CB9E4196

Q37297099-48990B90-8FB2-4450-8C3E-2D92983CF8F7

Q37297099-652E749B-B542-4DEA-B59D-B2E9C890AC3E

Q37297099-745A2A9F-4730-42C4-A062-C454B08E57CA

Q37297099-7FD04050-D144-444A-B0A6-2077985AB1E9

P304

Q37297099-1F7AA2B2-4D74-4921-98CF-9245E8E2F1EB

P31

Q37297099-F32B874B-E369-46D1-8BC3-CC34C06FC02D

P356

Q37297099-9081F382-90E9-44DF-BF39-FCF3DB54BDAD

P407

Q37297099-91C0DAAA-830A-4340-811D-56C767532D34

P433

Q37297099-3EFF4298-767D-4AC6-AE18-D74E15576FAE

P478

Q37297099-E455F5CC-6F0D-48B2-ACFF-CDF12D2EBF82

P577

Q37297099-D4C16792-27D8-4B65-B3F0-2D36DD7295B5

P5875

Q37297099-4AB11CA9-9CC5-46AF-B514-5469FAE4BDE8

P698

Q37297099-DBDC1912-A45B-4CDF-80B8-17ADB2CB9DE4

P932

Q37297099-4D6943BA-BF39-4767-94F6-56BD2FE0D6D9

P356

CIRCULATIONAHA.106.680157

P1433

P1476

Functional, cellular, and mole ...... ocardial ischemia in diabetes.

@en

P2093

Basel Ramlawi

http://www.w3.org/2001/XMLSchema#string

Frank W Sellke

http://www.w3.org/2001/XMLSchema#string

Jun Feng

http://www.w3.org/2001/XMLSchema#string

Munir Boodhwani

http://www.w3.org/2001/XMLSchema#string

Neel R Sodha

http://www.w3.org/2001/XMLSchema#string

Richard T Clements

http://www.w3.org/2001/XMLSchema#string

Shigetoshi Mieno

http://www.w3.org/2001/XMLSchema#string

Shu-Hua Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).

Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes

Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material.

Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications.

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia.

Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus.

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors.

P304

I31-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.106.680157

http://www.w3.org/2001/XMLSchema#string

P407

P433

11 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5994838

http://www.w3.org/2001/XMLSchema#string

P698

17846323

http://www.w3.org/2001/XMLSchema#string

P932

2723770

http://www.w3.org/2001/XMLSchema#string